Harshfine Chemopharma Private Limited - Company Profile

It is a chemicals and materials private limited company based in Ambernath, Maharashtra, India, established in 2011.
2011 Ambernath, Maharashtra, India Active
Last Updated:
Access Report
About Harshfine Chemopharma Private Limited

Harshfine Chemopharma Private Limited, a active private limited company, was established on 07 May 2011 in Ambernath, Maharashtra, India. Engaging in industrial chemicals within the manufacturing sector, it holds CIN: U24100MH2011PTC217168. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.

Formerly known as R. N. Heavy Equipments Private Limited, Harshfine Chemopharma Private Limited. It upholds a compliant status. Employing 6 professional, Its leadership includes Hanisha Motwani Chander (Director), Ashwin Meghji Vira (Director), Anupama Bhatnagar (Director). Past directors included Ankit Ulhas Trehan, Hanisha Motwani Chander, Ashwin Meghji Vira. It holds no open charges and ₹1.35 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No.29, Opp Ashu Organics Ltd Morivali Midc, Ambernath (E), Ambernath, Maharashtra, 421501.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24100MH2011PTC217168

  • Registration Number

    217168

  • Incorporation Date

    07 May 2011

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 14 Year, 9 Months
  • Last Filing with ROC 31 Mar 2025
  • Satisfied Charges ₹ 1.35 Cr
  • Revenue Growth **** -21.71%
  • Profit Growth **** -574.94%
  • Ebitda **** -177.76%
  • Net Worth -186.40%
  • Total Assets **** 15.28%
Company report

Harshfine Chemopharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Harshfine Chemopharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Harshfine Chemopharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Hanisha Motwani Chander Director 04 Jun 2019 Current
Ashwin Meghji Vira Director 29 Apr 2017 Current
Anupama Bhatnagar Director 27 Feb 2019 Current
Pandharinath Ananta Patil Additional Director 05 Oct 2024 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 30 Sep 2022 Past
Pramod Abcsdd Additional Director 23 Sep 2019 Past
Pramod Abcsdd Additional Director 23 Sep 2019 Past
Pramod Abcsdd Additional Director 07 Dec 2018 Past
Pramod Abcsdd Director 17 Dec 2018 Past
Pramod Abcsdd Additional Director 23 Sep 2019 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Harshfine Chemopharma.

Harshfine Chemopharma Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 21.71% decrease. The company also saw a substantial fall in profitability, with a 574.94% decrease in profit. The company's net worth observed a substantial decline by a decrease of 186.4%.

Harshfine Chemopharma revenue growth over time
Harshfine Chemopharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -21.71%
*******
*******
*******
*******
Revenue from Operations
*******
 -21.84%
*******
*******
*******
*******
Total Assets
*******
 15.28%
*******
*******
*******
*******
Profit or Loss
*******
 -574.94%
*******
*******
*******
*******
Net Worth
*******
 -186.40%
*******
*******
*******
*******
EBITDA
*******
 -177.76%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Harshfine Chemopharma?

In 2020, Harshfine Chemopharma had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹13,500,000.00

Charges Breakdown by Lending Institutions
  • Tjsb Sahakari Bank Limited : 1.35 Cr
Latest Charge Details
Date Lender Amount Status
05 Oct 2015 Tjsb Sahakari Bank Limited ₹1.35 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Harshfine Chemopharma?

Harshfine Chemopharma has a workforce of 6 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Harshfine Chemopharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Harshfine Chemopharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Harshfine Chemopharma
Recent Activity within the Organization
  • Annual General Meeting

    Harshfine Chemopharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Progress on Harshfine Chemopharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.

  • Director Appointment

    The activity Pandharinath Ananta Patil was appointed as a Additional Director was appointed as a Additional Director on 05 Oct 2024 & has been associated with this company since 1 year 4 months . was completed.

  • Director Appointment

    Progress on Hanisha Motwani Chander was appointed as a Director was appointed as a Director on 04 Jun 2019 & has been associated with this company since 6 years 8 months . was documented.

  • Director Appointment

    The activity Anupama Bhatnagar was appointed as a Director was appointed as a Director on 27 Feb 2019 & has been associated with this company since 6 years 11 months . was completed.

  • Director Appointment

    Progress on Ashwin Meghji Vira was appointed as a Director was appointed as a Director on 29 Apr 2017 & has been associated with this company since 8 years 9 months . was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Harshfine Chemopharma Private Limited?

The CIN of Harshfine Chemopharma Private Limited is U24100MH2011PTC217168.

Where is Harshfine Chemopharma Private Limited headquartered?

Harshfine Chemopharma Private Limited is headquartered at Plot No.29, Opp Ashu Organics Ltd Morivali Midc, Ambernath (E), Ambernath, Maharashtra, 421501.

When was Harshfine Chemopharma Private Limited incorporated?

Harshfine Chemopharma Private Limited was incorporated on 07 May 2011.

Who are the current directors of Harshfine Chemopharma Private Limited?

The current directors of Harshfine Chemopharma Private Limited are

What is the primary industry of Harshfine Chemopharma Private Limited?

The primary industry of Harshfine Chemopharma Private Limited is Manufacturing.

Is Harshfine Chemopharma Private Limited a listed company?

Harshfine Chemopharma Private Limited is unlisted.

What is the capital structure of Harshfine Chemopharma Private Limited?

The authorized capital of Harshfine Chemopharma Private Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Harshfine Chemopharma Private Limited?

The compliance status of Harshfine Chemopharma Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available